Brind.

Hoffmann-La Roche and DualityBio announced a partnership to develop cancer therapeutics, with John Zhu leading DualityBio.

1 report, 1 independent Updated Aug 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Hoffmann-La Roche

Keep exploring

The entities involved

Hoffmann-La Roche
Swiss healthcare company
- CEO Jack Roche emphasized portfolio and partnerships.Mon 20:51
- Roche Pharma Vietnam partners with the Bright Future Fund, which is led by Nguyen Thi Xuyen.Mon 20:51

Related events

A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.Jun 8

Coverage

Newest first; wire copies grouped

Aug 28bioxconomy.com